Emma Catherine Rappolt Costante

Emma is a corporate lawyer advising domestic and international clients on a range of business matters, including financings, mergers and acquisitions, go-public events, complex shareholder negotiations, corporate governance, commercial transactions, joint ventures and partnerships.

Emma's practice covers a broad range of sectors and industries, including life sciences, health care, SaaS, AI and quantum computing, clean tech, and natural resources. A large part of Emma’s practice focuses on supporting innovative growth companies and particularly in the life science industry. She helps create negotiated solutions among stakeholders, including founder exits, government contracts and complex shareholder agreements.

Radical Ventures and Khosla Ventures on their investment in Veeda AI, a physical AI company focused on developing world models for robotics applications

DCx Biotherapeutics in its licensing and acquisition of certain assets from Repare Therapeutics

Convergint in connection with its purchase of the security division of Delco Automation Inc.

Eupraxia in connection with its C$44.5-million non-brokered private placement of preferred shares